Edward Dul Selected Research

N- (3- ((2- (4- amino- 1,2,5- oxadiazol- 3- yl)- 1- ethyl- 1H- imidazo(4,5- c)pyridin- 6- yl)oxy)phenyl)- 4- ((2- (4- morpholinyl)ethyl)oxy)benzamide

1/2007

Novel Rho kinase inhibitors with anti-inflammatory and vasodilatory activities.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Edward Dul Research Topics

Disease

2	Neoplasms (Cancer) 02/2012 - 11/2003
1	Lymphoma (Lymphomas) 02/2012
1	B-Cell Lymphoma (Lymphoma, B Cell) 02/2012
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2008
1	Hypertension (High Blood Pressure) 01/2007
1	Chronic Disease (Chronic Diseases) 01/2007
1	Colonic Neoplasms (Colon Cancer) 11/2003

Drug/Important Bio-Agent (IBA)

2	Histones (Histone)IBA 02/2012 - 11/2003
2	rho-Associated KinasesIBA 11/2008 - 01/2007
1	Polycomb Repressive Complex 2IBA 02/2012
1	Histone MethyltransferasesIBA 02/2012
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 02/2012
1	Lysine (L-Lysine)FDA Link 02/2012
1	4- (7- ((3- amino- 1- pyrrolidinyl)carbonyl)- 1- ethyl- 1H- imidazo(4,5- c)pyridin- 2- yl)- 1,2,5- oxadiazol- 3- amineIBA 01/2007
1	N- (3- ((2- (4- amino- 1,2,5- oxadiazol- 3- yl)- 1- ethyl- 1H- imidazo(4,5- c)pyridin- 6- yl)oxy)phenyl)- 4- ((2- (4- morpholinyl)ethyl)oxy)benzamideIBA 01/2007
1	theasinensin AIBA 11/2003
1	entinostat (MS 275)IBA 11/2003
1	Histone Deacetylase InhibitorsIBA 11/2003